ReferenceID 5661

Maackiain protects against sepsis via activating AMPK/Nrf2/HO-1 pathway

Int Immunopharmacol

Sepsis is a life-threatening medical condition caused by infection-triggered aberrant immune responses, leading to host tissue and organ injury. Despite advances in medical interventions, the mortality rate for septic sh

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Ingredient: 1Reference: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final reference record.

Reference Id
5661
Evidence Id
22251
Core Evidence Id
22251
Source Reference Id
4551
Herb2 Reference Id
HBREF005348
Subject Paper Key
HBIN034075_35405595
Pubmed Id
35405595
Doi
10.1016/j.intimp.2022.108710
Paper Title
Maackiain protects against sepsis via activating AMPK/Nrf2/HO-1 pathway
Paper Abstract
Sepsis is a life-threatening medical condition caused by infection-triggered aberrant immune responses, leading to host tissue and organ injury. Despite advances in medical interventions, the mortality rate for septic shock remains high. Recent studies highlight the role of oxidative stress in the occurrence and development of sepsis, providing a potential therapeutic target for preventing sepsis-associated organ injury. In this study, we showed that Maackiain, a natural compound isolated from Sophora flavescens, exerted a protective role in a cecal ligation and puncture (CLP)-induced murine model of sepsis. Maackiain treatment reduced organ injury, and mitigated systematic inflammation and oxidative stress in septic mice. Maackiain also reduced the levels of inflammatory cytokines and reactive oxygen species (ROS) in RAW264.7 macrophage cells stimulated with lipopolysaccharide (LPS). We further demonstrated that Maackiain initiated activation of nuclear factor erythroid 2-related factor 2 (Nrf2)/heme oxygenase-1 (HO-1) pathway in RAW264.7 cells in an AMP-activated protein kinase (AMPK)-dependent way. Moreover, inhibition of AMPK/Nrf2 axis abrogated the anti-inflammatory and anti-oxidant effects of Maackiain both in vitro and in vivo. Collectively, our study indicates that Maackiain treatment inhibits inflammatory response and oxidative stress via activation of AMPK/Nrf2/HO-1 pathway, thus exerting a protective effect against sepsis, providing an alternative option for sepsis prevention.
Journal
Int Immunopharmacol
Publish Year
2022
Experiment Subject
mouse; raw264.7 cells; raw264.7 macrophage cells
Experiment Type
Animal & Cell Experiment
Phenotype Related
Organ Injury; Sepsis; Septic Shock; Sepsis-associated Organ Injury; Septic; Cecal Ligation And Puncture
Paper Title Cn
Paper Title En
Maackiain protects against sepsis via activating AMPK/Nrf2/HO-1 pathway
Bilingual Status
semi_complete